Prolia 60 mg solution for injection in pre-filled syringe, LY06006
LY06006/MRCT-301
Phase 3 small_molecule active
Quick answer
Prolia 60 mg solution for injection in pre-filled syringe, LY06006 for Postmenopausal osteoporosis is a Phase 3 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Postmenopausal osteoporosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active